Dr. Frank Smith Appointed President of XenoSTART to Lead Oncology Developments Frank Smith has been appointed as President of XenoSTART, bringing expertise to enhance preclinical cancer research and drug development.

Dr. Frank Smith Appointed President of XenoSTART to Lead Oncology Developments #USA #San_Antonio #START_Center #XenoSTART #Frank_Smith